Custom Disease/Control iPSC Generation Service
Human induced pluripotent stem cells (iPSCs) have emerged as a powerful tool for studying various diseases, particularly genetic disorders. By reprogramming somatic cells into pluripotent stem cells, researchers can create patient-specific iPSCs that carry the genetic mutations associated with specific diseases. These iPSCs can then be differentiated into various cell types to study disease mechanisms, screen drugs, and develop potential therapies.
Expert scientists at Creative Biolabs are passionate about offering disease-related iPSC-derived cells/mutant iPSCs you need to release you from the stressful and excessive workload process of cell reprogramming - giving you more time to focus on research.
Fig. 1 Use of disease-relevant iPSCs to treat neurological diseases.1
Our iPSC Disease Models
- Patient-derived iPSC Disease Models
Patient-derived iPSC disease models are reprogrammed from innate somatic cells without any genetic manipulation. These models retain the genetic background of the individual and are reprogrammed to a pluripotent state, thereby providing insights into how diseases manifest in specific patient populations.
- Genetically Engineered iPSC Disease Models
Genetically engineered iPSC disease models involve genetic modifications to introduce specific mutations related to a disease. These models can be generated using techniques such as CRISPR/Cas9 or other gene-editing tools.
- Induced iPSC Disease Models
By introducing exogenous stimuli (e.g., Aβ1-42 peptide), researchers can create disease-like states in iPSC-derived cells, allowing for a better understanding of disease mechanisms, drug responses, and potential therapeutic interventions.
Our iPSC Control Models
- Healthy Control-derived iPSC Models
Healthy control-derived iPSC models are created from somatic cells (like skin or blood cells) of healthy individuals. These cells are reprogrammed into a pluripotent state, allowing them to differentiate into any cell type.
- Isogenic Control iPSC Models
Isogenic control iPSC models are derived from individuals with known genetic backgrounds. These lines are generated by either introducing specific disease-related mutations into healthy iPSCs or by correcting such mutations in patient-derived iPSCs, ensuring that no additional genetic alterations are made.
Disease Model Platforms
We are proud to provide disease-related iPSC-derived cells or mutant iPSCs with you for research use only, which significantly contribute to understanding various pathologies and the development of targeted therapies.
Neurological Diseases | Relevant Mutations | Available Cell Types |
---|---|---|
Alzheimer's disease | APOE 4/4, APOE 3/3, APOE 2/2, APOE 3/4, APOE 2/3, TREM2 KO, TREM2 R47H, APP A673V, APP A673T and PSEN M146L | NSCs, Cortical Neurons, GABAergic Neurons, Glutamatergic Neurons, Astrocytes and Microglia |
Parkinson's disease | Ataxin-3, PINK1, PARKIN, PARK2, SNCA A53T and LRRK2 | NSCs, Dopaminergic Neurons, Glutamatergic Neurons, Striatal Neurons, Astrocytes and Microglia |
Huntington's Disease | HTT 50 CAG | NSCs, Cortical Neurons, Glutamatergic Neurons, Striatal Neurons, |
Amyotrophic Lateral Sclerosis | SOD1, TDP43 and C9ORF72 | NSCs, Motor Neurons, Sensory Neurons |
Applications
- Disease Modeling
- Drug Discovery
- Toxicology Studies
Related Services
|
|
Reference
- McTague, Amy et al. "Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies." Front Genome Ed. 2021;3:630600. Distributed under Open Access license CC BY 4.0. The original image was modified.
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)